ES2144857T3 - Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso. - Google Patents

Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.

Info

Publication number
ES2144857T3
ES2144857T3 ES97919465T ES97919465T ES2144857T3 ES 2144857 T3 ES2144857 T3 ES 2144857T3 ES 97919465 T ES97919465 T ES 97919465T ES 97919465 T ES97919465 T ES 97919465T ES 2144857 T3 ES2144857 T3 ES 2144857T3
Authority
ES
Spain
Prior art keywords
manufacture
diseases
treatment
nervous system
benzonaphthalenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919465T
Other languages
English (en)
Inventor
Xavier Vige
Jesus Benavides
Braham Shroot
Veronique Taupin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Application granted granted Critical
Publication of ES2144857T3 publication Critical patent/ES2144857T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Abstract

UTILIZACION DE COMPUESTOS DE FORMULA GENERAL (I) PARA LA FABRICACION DE MEDICAMENTOS UTILES EN EL TRATAMIENTO DE LAS NEUROPATIAS PERIFERICAS, DE LAS ENFERMEDADES NEURODEGENERATIVAS CENTRALES Y DE LAS ENFERMEDADES AUTOINMUNES DEL SISTEMA NERVIOSO.
ES97919465T 1996-04-05 1997-04-02 Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso. Expired - Lifetime ES2144857T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604359A FR2747041B1 (fr) 1996-04-05 1996-04-05 Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des neuropathies

Publications (1)

Publication Number Publication Date
ES2144857T3 true ES2144857T3 (es) 2000-06-16

Family

ID=9490993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919465T Expired - Lifetime ES2144857T3 (es) 1996-04-05 1997-04-02 Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.

Country Status (23)

Country Link
US (1) US6043280A (es)
EP (1) EP0900078B1 (es)
JP (1) JP2000512619A (es)
KR (1) KR20000005179A (es)
CN (1) CN1221341A (es)
AT (1) ATE189385T1 (es)
AU (1) AU717704B2 (es)
BR (1) BR9708511A (es)
CA (1) CA2250755A1 (es)
CZ (1) CZ317698A3 (es)
DE (1) DE69701258T2 (es)
ES (1) ES2144857T3 (es)
FR (1) FR2747041B1 (es)
GR (1) GR3033061T3 (es)
HU (1) HUP9902167A3 (es)
NO (1) NO984651L (es)
NZ (1) NZ332158A (es)
PL (1) PL329219A1 (es)
PT (1) PT900078E (es)
RU (1) RU2160098C2 (es)
SK (1) SK133398A3 (es)
WO (1) WO1997037648A1 (es)
ZA (1) ZA972875B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials
WO2001034633A2 (en) * 1999-11-12 2001-05-17 Fred Hutchinson Cancer Research Center Methods for treatment of human huntington's disease and methods of screening for active agents
US6914074B2 (en) * 2001-12-13 2005-07-05 Wyeth Substituted phenyl naphthalenes as estrogenic agents
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
MX361414B (es) 2010-09-01 2018-12-05 Univ Jefferson Composición y método para reparación y regeneración muscular.
KR101981930B1 (ko) 2017-08-10 2019-05-27 주식회사 에니텍시스 랜딩 장치

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455248A (en) * 1993-09-14 1995-10-03 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts, and compositions and method of use thereof

Also Published As

Publication number Publication date
HUP9902167A2 (hu) 2000-04-28
ATE189385T1 (de) 2000-02-15
CN1221341A (zh) 1999-06-30
DE69701258T2 (de) 2000-12-21
DE69701258D1 (de) 2000-03-09
AU717704B2 (en) 2000-03-30
KR20000005179A (ko) 2000-01-25
HUP9902167A3 (en) 2000-07-28
NO984651L (no) 1998-12-03
CA2250755A1 (fr) 1997-10-16
FR2747041B1 (fr) 1998-05-22
NO984651D0 (no) 1998-10-05
US6043280A (en) 2000-03-28
ZA972875B (en) 1997-10-31
PL329219A1 (en) 1999-03-15
AU2392797A (en) 1997-10-29
WO1997037648A1 (fr) 1997-10-16
CZ317698A3 (cs) 1999-02-17
PT900078E (pt) 2000-07-31
NZ332158A (en) 2000-06-23
JP2000512619A (ja) 2000-09-26
GR3033061T3 (en) 2000-08-31
EP0900078B1 (fr) 2000-02-02
EP0900078A1 (fr) 1999-03-10
FR2747041A1 (fr) 1997-10-10
RU2160098C2 (ru) 2000-12-10
SK133398A3 (en) 1999-12-10
BR9708511A (pt) 1999-08-03

Similar Documents

Publication Publication Date Title
ES2191192T3 (es) Tienopirimidinas.
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
ES2086623T3 (es) Azaheterociclilmetil-cromanos como principios activos para el tratamiento de enfermedades del sistema nervioso central.
ES2188793T3 (es) Agente para el tratamiento de las enfermedades neurodegenerativas.
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
YU1097A (sh) 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
ES2097341T3 (es) Indoles sustituidos como farmacos para el tratamiento del sida.
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ES2184106T3 (es) Utilizacion del derivado de k-252a en el tratamiento de trastornos del sistema nervioso periferico o central, y de la hiperproduccion de citoquinas.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
TR200200716T2 (tr) Ketiyapin granülleri
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
AR002272A1 (es) Uso de amidas de fenilciclohexilcarboxilicos
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
ES2148600T3 (es) Derivados de indol sustituidos.
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 900078

Country of ref document: ES